{
    "title": "Regeneron buys rights to cancer drug Libtayo from Sanofi",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10878611/Regeneron-buys-rights-cancer-drug-Libtayo-Sanofi.html",
    "date": "2022-06-02",
    "keywords": [
        "libtayo",
        "drug",
        "sanofi",
        "cancer",
        "drugmaker",
        "deal",
        "payment",
        "treatment",
        "june",
        "thursday",
        "sa",
        "collaboration",
        "agreement",
        "country",
        "acquisition",
        "step",
        "goal",
        "oncology",
        "leader",
        "schleifer",
        "executive",
        "company",
        "regeneron",
        "market",
        "review",
        "union",
        "nonsmall",
        "cell",
        "lung",
        "nsclc",
        "combination",
        "chemotherapy",
        "royalty",
        "approval",
        "fda",
        "regulator",
        "milestone",
        "buyback",
        "reporting",
        "khandekar",
        "bengaluru",
        "gv",
        "clercq",
        "paris",
        "editing",
        "aditya",
        "soni"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}